Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.28
14.34
-1.06
-7.39%
Share Warrants & Outstandings
Total Reserve
204.71
405.26
-200.55
-49.49%
Shareholder's Funds
239.95
422.82
-182.87
-43.25%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
7.90
-7.90
-100.00%
Secured Loans
0.00
7.90
-7.90
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.07
-18.36
21.43
116.72%
Other Long Term Liabilities
8.30
19.98
-11.68
-58.46%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.04
10.19
-9.15
-89.79%
Total Non-Current Liabilities
12.41
19.71
-7.30
-37.04%
Current Liabilities
Trade Payables
9.73
63.51
-53.78
-84.68%
Other Current Liabilities
15.16
26.00
-10.84
-41.69%
Short Term Borrowings
0.00
100.99
-100.99
-100.00%
Short Term Provisions
1.01
0.98
0.03
3.06%
Total Current Liabilities
25.90
191.47
-165.57
-86.47%
Total Liabilities
278.26
634.00
-355.74
-56.11%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.47
359.24
-265.77
-73.98%
Less: Accumulated Depreciation
7.25
147.33
-140.08
-95.08%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
86.23
211.91
-125.68
-59.31%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
12.79
-12.79
-100.00%
Intangible assets under development
0.00
0.32
-0.32
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
14.70
-14.70
-100.00%
Long Term Loans & Advances
1.33
29.47
-28.14
-95.49%
Other Non Current Assets
21.29
0.37
20.92
5,654.05%
Total Non-Current Assets
117.07
274.49
-157.42
-57.35%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
15.20
130.66
-115.46
-88.37%
Sundry Debtors
13.18
137.21
-124.03
-90.39%
Cash and Bank
128.73
18.02
110.71
614.37%
Other Current Assets
1.66
6.40
-4.74
-74.06%
Short Term Loans and Advances
2.42
67.23
-64.81
-96.40%
Total Current Assets
161.19
359.51
-198.32
-55.16%
Net Current Assets (Including Current Investments)
135.29
168.03
-32.74
-19.48%
Total Current Assets Excluding Current Investments
161.19
359.51
-198.32
-55.16%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
278.26
634.00
-355.74
-56.11%
Contingent Liabilities
16.17
5.44
10.73
197.24%
Total Debt
0.00
108.89
-108.89
-100.00%
Book Value per share (adjusted)
36.08
147.47
-111.39
-75.53%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 86.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Current Assets
Current Assets 161.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024






